CX NEWS
Durability of endovascular aneurysm repair and the NICE guidelines
A CX 2019 special session highlighted the durability of endovascular aneurysm repair (EVAR) and the implications of the UK National Institute for Health and Care Excellence (NICE) draft aortic aneurysm guidelines. The final publication [...]
Optimising surveillance and reintervention strategy following elective EVAR
Roger Greenhalgh (London, UK) interviewed Fiona Rohlffs (Hamburg, Germany), Maarit Venermo (Helsinki, Finland) and David Epstein (Granada, Spain) at the CX Live studio after their ‘Optimising surveillance and reintervention strategy following elective EVAR’ session. [...]
Medical device industry leaders call for three big changes to “devastating” EU MDR legislation
Industry leaders say approximately 50% of all medical devices will be withdrawn from the market; around 30% of manufacturers will not survive and patients might be at risk as a result of the European [...]
New APERTO AVF RCT data show DCB reduces restenosis significantly more than high-pressure balloon alone
Matteo Tozzi (Varese, Italy) discusses new data from the APERTO AVF study, the first randomised trial in China to compare the safety and efficacy of the APERTO drug-coated balloon (DCB; Cardionovum) with a high-pressure [...]
Comprehensive innovation programme gives insights into the technologies of the future
The CX Innovation Programme showcased technological developments happening in all areas of the Charing Cross Symposium: acute stroke, aortic, peripheral, venous, vascular access, and wound care. Additionally, a new “Dragons’ Den” winner was crowned. [...]
TEVAR performed outside the IFU has “dramatically worse outcomes”
Dittmar Boeckler (Heidelberg, Germany) tells CX Live that treating patients with thoracic endovascular aortic repair (TEVAR) outside the instructions for use (IFU) has a dramatic effect on patient outcomes after the procedure. “We observed [...]